Foundation Venture Capital Group, LLC, announced today that it has made a $500,000 commitment to Snowdon, Inc.
INFO SOURCES
Foundation Venture Capital Group, LLC
FIRMS
Snowdon, a drug discovery and development company focused on three major therapeutic areas -- cancer, acute and chronic pain, and infectious diseases.
Foundation Venture Capital Group, LLC, was established in March 2006 to invest exclusively in research at the University of Medicine and Dentistry of New Jersey. Both Foundation Venture Capital Group and the Foundation of UMDNJ are affiliates of the New Jersey Health Foundation.
Supporting Material
